Longwood Capital Partners »

Mereo Biopharma Group Plc ads shares owned by Longwood Capital Partners

Quarter-by-quarter ownership of Mereo Biopharma Group Plc ads (MREO) shares owned by Longwood Capital Partners from 13F filings

Historical chart of Longwood Capital Partners investment in Mereo Biopharma Group Plc ads

Tip: Access up to 7 years of quarterly data

All positions including Mereo Biopharma Group Plc ads held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mereo Biopharma Group Plc ads by Longwood Capital Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.2M 1.3M 4.11
2024-06-30 $2.4M 677k 3.60
2024-03-31 $1.3M 398k 3.30

More positions owned by Longwood Capital Partners

Vaxcyte (PCVX)
Ocular Therapeutix (OCUL)
Tourmaline Bio (TRML)
Insmed Com Par $.01 (INSM)
Enliven Therapeutics (ELVN)
Crinetics Pharmaceuticals In (CRNX)
Arcellx Common Stock (ACLX)
Mereo Biopharma Group Spon Ads (MREO)
Revolution Medicines (RVMD)
Taysha Gene Therapies Com Shs (TSHA)
Terns Pharmaceuticals (TERN)
Kura Oncology (KURA)
Aadi Bioscience (AADI)
Rocket Pharmaceuticals (RCKT)
Praxis Precision Medicines I (PRAX)

View all positions for Longwood Capital Partners

Top funds holding Mereo Biopharma Group Plc ads

Rubric Capital Management
Henderson Group
Adage Capital Partners GP
Rock Springs Capital Management
Mangrove Partners
Deerfield Management Company
Millennium Management
Frazier Life Sciences Management
683 Capital Management
Alkeon Capital Management
Clearline Capital
Tejara Capital
Goldman Sachs Group
Renaissance Technologies
Longwood Capital Partners

View all funds holding Mereo Biopharma Group Plc ads